CAMRF OTC
Camurus AB
1W: +0.0%
1M: -3.5%
3M: +14.3%
YTD: -8.0%
1Y: -10.3%
3Y: +183.1%
5Y: +378.7%
$61.75
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$3.7B
52W Range54-71
Volume200
Avg Volume110
Beta0.52
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOSven Fredrik Tiberg
Employees285
SectorHealthcare
IndustryBiotechnology
IPO Date2017-12-11
Websitecamurus.com
Rydbergs torg 4
Lund, SN 224 84
SE
Lund, SN 224 84
SE
46 4 62 86 57 30
About Camurus AB
Camurus AB operates as a research based pharmaceutical company. The firm engages in the research, development and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer and endocrine disorders. The company was founded by Kare Larsson in 1991 and is headquartered in Lund, Sweden.
Latest News
Camurus AB (publ) reports results
Fish On First Prospects Report: Cam Cannarella's stock soars; hit machine Luis Arana - Fish On First
Trakya Cam Stock - Friday sector check and weekly review - AD HOC NEWS
Cam Ward's Fantasy stock rises under new Titans play-caller Brian Daboll - CBS Sports
Trakya Cam Sanayii A.?. Stock (TRATRAKY91K7): valuation focus for glass producer as investors weigh - AD HOC NEWS
Recent Insider Trades
No insider trades found